Purpose: To analyze conjunctival cytological features 1 month after pterygium excision using limbo-conjunctival autograft (LCA) with and without intraoperative mitomycin C and to assess tissue short-term evolution in both situations.
3 study nasal GCD was not lower but similar to postoperative temporal data of the same eye (p=0.164; paired t test).
Conclusions:
LCA is a good technique for conjunctiva early recovery. When mitomycin C was added, the GCD reduction was lower than described using other surgical techniques. Mitomycin C, in optimal concentration and exposure, associated with LCA could be a good clinical option to minimize pterygium recurrence.
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INTRODUCTION
Pterygium is a common ocular surface disease characterized by the encroachment of a fleshy fibrovascular formation from the bulbar conjunctiva across the limbus, invading the cornea. Theories of pterygium pathogenesis have implicated ultraviolet light exposure as a major causative factor 1, 2 Excessive exposure to UVB could damage limbal stem cells, leading to aberrant wound healing responses 3 . This wing-shaped lesion is often associated with inflammation, increased corneal astigmatism, obstructed vision, and unfavorable cosmetic effect 4 Different surgical techniques have been used to remove pterygium and prevent recurrence. Evidence indicates that bare sclera excision results in a significantly higher pterygium recurrence rate than excision accompanied by using certain adjuvants 5, 6 , such as mitomycin C, and conjunctival (CA) or limbo-conjunctival autograft (LCA). Comparisons recently revealed that to use a combination of CA or LCA with mitomycin C could further reduce pterygium recurrence rate compared with a single adjuvant 6 .
Mitomycin C is an antineoplastic-antibiotic agent produced by Streptomyces caespitosus that inhibits the synthesis of DNA, proteins and cellular RNA and is a potent inhibitor of fibroblasts proliferation. Drug use has improved not only recurrence rate after pterygium surgery but also the surgical results in other ocular disease, such as glaucoma, or corneal and conjunctival intraepithelial neoplasia 7, 8, 9 .
Optimal mitomycin C concentration and exposure time have been analyzed to prevent its deleterious effects 10, 11, 12, 13 and single intraoperative low dose of the 5 drug is safer than postoperative topical daily application and it is effective reducing pterygium recurrence rates 14, 15 . Delay in conjunctival epithelium healing could be early detected by impression cytology or in-vivo confocal microscopy when the chemoadjuvant was applied 16, 17 . Important changes, mainly in goblet cell density, were found few weeks after surgery that lasted for long periods, even when mitomycin C was applied in optimal conditions. Nevertheless, tissue evolution after pterygium excision not only depends on mitomycin C use but other adjuvants seem to be determining factors in the process. In fact, autografting (with CA) seems to promote tissue healing compared to bare sclera or bare sclera with mitomycin C 16 . An optimal combination of adjuvants may be the key to reduce recurrences with early tissue recovery or, at least, with minimal alterations in short-term, suggesting a faster conjunctival recovery. However, to our knowledge, conjunctival epithelial phenotypes after LCA or combining LCA with mitomycin C have not been previously reported in short or long-term.
The aim of this study is to compare conjunctival cytological features 1 month after pterygium excision using limbo-conjunctival autograft (LCA) with and without intraoperative mitomycin C and to assess tissue short-term evolution in both situations. Analysis of epithelial changes triggered by each specific adjuvant combination could improve the current risk/benefit knowledge of these strategies, and evidence-based decisions in pterygium clinical management.
METHODS
Fifty-nine eyes of 59 patients with primary nasal pterygium, 37 males and 22 females, average age 43 ± 11.87, range 22-76 years, were enrolled in the 
Statistical analysis
After an exploratory data analysis, the variables were tested for normality by the Kolmogorov-Smirnov test. ANOVA was used to assess differences in the 
Preoperative comparison between MMC+ and MMC-
All the preoperative data were, in mean, within the normal range, except for a slight goblet cell hyperplasia in the area of the lesion in MMC+. Nevertheless, statistical comparison between the two groups displayed no significant differences in all the initial cytological features (p=0.079 for GCD and p=0.245 for N/C; ANOVA).
Postoperative comparison between MMC+ and MMC-
One month after surgery, N/C were significantly higher in MMC+ than in MMCin both temporal and nasal zones (p=0.000 and p=0.007, respectively; ANOVA) but the mean exhibited normal values for both groups in all the studied locations. Nasal GCD was significantly lower in MMC+ than in MMC-(p= 0.000; ANOVA). This difference was clinically relevant since the mean value in MMC+ was slightly below normal values while in MMC-remained normal.
Conjunctival short-term evolution. Postoperative vs preoperative cytological features
Paired t test was applied comparing cytological characteristics before and 1 month after pterygium excision in MMC-and the analysis was repeated for 
Conjunctival short-term evolution. Postoperative Comparison between temporal and nasal conjunctiva
In order to quantify altered topographical distribution of GCD and subsequently to contrast our results with other previous described in the literature, comparisons between nasal and temporal conjunctiva in MMC-, one month after surgery, were carried out and the same analysis was repeated for MMC+.
A greater GCD in nasal than temporal area was found in MMC-(p=0.000; . However, postoperative nasal GCD data in MMC+ were similar to temporal data, (p=0.164; paired t test). Although this result was indicative of an abnormal topographical distribution, the data revealed a clearly milder GCD reduction in the injured area than that previously described using mitomycin C without autograft, as is discussed in the next section.
DISCUSSION
The findings of this study demonstrate that conjunctival epithelium has already recovered its normal characteristics one month after nasal pterygium excision with LCA. When combined LCA with mitomycin C, a significant reduction of nasal GCD was observed while the rest of cytological features remained normal in the two studied zones one month after surgery. Postoperative nasal and temporal GCD were similar in MMC+. Hence, changes in topographical distribution produced by mitomycin C could be considered as relatively modest when LCA was used.
Preoperative MMC+ mean values showed a slight goblet cell hyperplasia in the area of the lesion, which is consistent with previous reports about epithelial phenotype of pterygium 16, 21 but was not disclosed in preoperative MMC-mean values of the same zone. By contrast, the more definitive results of ANOVA displayed no statistical differences in initial conditions between the two groups.
Actually, goblet cell density has always shown a high variability in both healthy epithelial conjunctiva 20, 22 and pterygium lesion 16, 21, 23, 24 and seems to be closely linked with tear osmolarity and ocular surface inflammation 25, 26 both conditions related with pterygium 4, 27 . This complex interaction would be the cause of the high variability observed in the studies and could explain the more apparent than real differences in GCD between the groups before the surgery.
Non secretory cells of conjunctival epithelium retained their normal phenotype one month after surgery in both surgical strategies and did not show squamous metaplasia, usually associated with keratoconjunctivitis sicca and different cicatrizing diseases and ocular irritation disorders 28, 29 . In fact, this is an expected result since none of the surgical techniques, which were used before, seems to trigger this kind of tissue alteration 16, 23, 30 . However, squamous metaplasia was reported in conjunctival epithelium when mitomycin C drops were used in an intensive topical treatment for primary acquired melanosis with atypia 31 . In the other hand, slight scamous metaplasia has been recently described in 31.3% of the samples (16 eyes) from the pterygium side, 6 months after excision with limbal autograft without mitomycin C 32 . Authors suggested that it might be related to recurrence.
Eyes with LCA without mitomycin C showed the same conjunctival phenotype 1 month after than before the surgery confirming this surgical strategy as a good 12 solution for a rapid epithelial recovery. Autograft promotion of conjunctival healing may be slower using CA than LCA since 6 months were necessary to achieve similar cytological results than in fellow control eyes 16 . Further comparative studies, applying the same design, are necessary to clarify this question, investigating the limbal postoperative condition with a confocal microscopy analysis.
Despite certain risk of limbal damage at the donor site of the graft 33 , LCA is one of the best choices for pterygium management 5, 6 . It is safe, with acceptable recurrence rate, and could be more effective than CA in prevent regrown of recurrent pterygia 34 . Nevertheless, as we have commented in the introduction section, using a combination of conjunctival or limbal autograft with mitomycin C further reduces the recurrence rate compared with conjunctival or limbal autograft or mitomycin C alone 6 .
Eyes with LCA and mitomycin C showed a reduction in nasal GCD that led to abnormal results in this zone. GCD decrease has been also described in previous cytological assessments after bare sclera excision with intraoperative mitomycin C 16, 23, 30 . The drug seems to delay GCD recovery regardless of the surgical technique chosen. However, this choice could determine cell loss magnitude and duration. Indeed, GCD decrease produced by mitomycin C combined with bare sclera excision seems to be more severe and prolonged than that triggered by the combination of the drug with LCA. Solomon and coworkers 30 reported a 4-fold decrease at the excision area (nasal) when compared with the contralateral nonoperated side (temporal) at a mean of 77.2 months after the surgery (range, 72-84 months after surgery). Far from it, in our study GCD maintained similar values in nasal than temporal side 1 month after 13 pterygium excision. These differences are plausible since autograft (using CA) has been described as a clear promoter of conjunctival healing in pterygium excision 16 . This quality may be due to the presence of graft basement membrane that serves as a substrate for the regenerating epithelium 16, 18 . LCA and mitomicyn C combination with a careful patient selection could be a good choice for pterygium management in terms of risk/benefit ratio. The present study provides evidence in this sense. This adjuvant combination not only seems to minimize drug toxicity but reduce the percentage of recurrence.
Nevertheless, further assessments with large samples are necessary to ratify this therapeutic issue.
In conclusion, pterygium excision with LCA seems to be an adequate technique to achieve a rapid conjunctival recovery and could minimize goblet cell alteration when mitomycin C was added to further reduce recurrences. The more modest drug epithelial toxicity one month after application clearly evidences the protective value of LCA. Mitomycin C, in optimal concentration and exposure, associated with LCA could be a good clinical option to minimize pterygium recurrence.
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